New Device in Testing May SAVE Failed Fistulas

Balloon angioplasty has been to open narrowing fistulas, but the narrowing often recurs. Now, a first patient has been enrolled in the MedAlliance SAVE study, using a balloon coated with sustained-release sirolimus to apply the drug to the inside of a fistula. This approach has been effective in the heart and other blood vessels.

Read the full article » | Posted 05-12-2020

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026